A clinical case of a 10-month-old child with severe Covid 19 with diarrheal syndrome ended fatally
DOI:
https://doi.org/10.2478/AMB-2024-0081Keywords:
COVID-19, infant, diarrhea, MIS-cAbstract
At the beginning of the COVID-19 pandemic, it was assumed that children were at low risk of infection and that their infection was milder than adults. With an increase in the number of pediatric cases of SARS-CoV-2 infection associated with manifestations of hyperinflammation, the condition of multisystem inflammatory syndrome in children (MIS-C) was defined. We present a clinical case of a 10-month-old male child hospitalized in the Clinic of Infectious Diseases at University Hospital in Stara Zagora, Bulgaria, with a COVID-19. The patient had a number of co-morbidities, including protein-calorie malnutrition, chronic respiratory failure and
bronchopulmonary dysplasia. During the hospital stay, he had an active diarrhea syndrome, with evidence of pneumonia and respiratory failure. In the clinical course, a progressive worsening of the condition with signs of multiple organ failure, increase in inflammatory markers and deterioration of coagulation indicators were observed. Placement in the ICU and the inclusion
of artificial pulmonary ventilation were required, but after an 18-day hospital stay, the patient died. In conclusion, this was an acute case of COVID-19 in an infant that started with respiratory and gastrointestinal manifestations that progressed to MIS-C with multiple organ failure leading to death. We believe that the reason for this is the compromised immune status in connection with the highly damaged premorbid terrain and young age.
References
White-Dzuro G, Gibson LE, Zazzeron L, et al. Multisystem effects of COVID-19: a concise review for practitioners Postgrad Med, 2021;133(1),20-27. doi: 10.1080/00325481. 2020.1823094.
Coronavirus Resource Center . Available from: https://coronavirus.jhu.edu/
Lee IC, Huo TI, Huang YH. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc 2020;83,521–523. doi:10.1097/JCMA.0000000000000319
Schultz CM, Burke LA, Kent DA. A Systematic Review and Meta-analysis of the Initial Literature Regarding COVID-19 Symptoms in Children in the United States. J Pediatr Health Care, 2023;37(4),425-437. doi: 10.1016/j.pedhc.2023.02.006.
Blatz AM, Randolph AG. Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents. Crit Care Clin, 2022;38(3),571-586. doi: 10.1016/j. ccc.2022.01.005.
Poeta M, Nunziata F, M Del Bene, et al. Diarrhea Is a Hallmark of Inflammation in Pediatric COVID-19. Viruses. 2022;14(12), 2723. doi: 10.3390/v14122723
DeBiasi RL, Harahsheh AS, Srinivasalu H, et al. Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing. J Pediatr. 2021;237:125-135.e18
Tsankov BK, Allaire JM, Irvine MA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2021 Feb;103:246-256
Assa A, Benninga MA, Borrelli O, et al. Gastrointestinal Committee of ESPGHAN. Gastrointestinal Perspective of Coronavirus Disease 2019 in Children-An Updated Review. J Pediatr Gastroenterol Nutr. 2021;73(3),299-305. doi: 10.1097/MPG.0000000000003204.
Lo Vecchio A, Garazzino S, Smarrazzo A, et al. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome. JAMA 2021;4(12),e2139974. doi: 10.1001/jamanetworkopen.2021.39974.
Rebecca C. Woodruff, PhD, MPH, Risk Factors for Severe COVID-19 in Children, Pediatrics. 2022;149 (1), e2021053418. doi: 10.1542/peds.2021-053418. Epub 2021 Dec 22.
Gupta V, Singh A, Ganju S, et al. Severity and mortality associated with COVID-19 among children hospitalised in tertiary care centres in India: a cohort study. Lancet Reg Health Southeast Asia. 2023;13:100203. doi: 10.1016/j.lansea.2023.100203.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 P. Parusheva, L. Pekova, S. Angelova (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.